サンプル依頼リスト カート
  • English
  • Korean
表紙：前頭側頭型障害治療の世界市場規模調査＆予測：薬剤クラス別、適応疾患別、流通チャネル別、地域別分析、2023-2030年
市場調査レポート
商品コード
1303537

前頭側頭型障害治療の世界市場規模調査＆予測：薬剤クラス別、適応疾患別、流通チャネル別、地域別分析、2023-2030年

Global Frontotemporal Disorders Treatment Market Size study & Forecast, by Drug Class, By Disease Indication, By Distribution Channel, and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
前頭側頭型障害治療の世界市場規模調査＆予測：薬剤クラス別、適応疾患別、流通チャネル別、地域別分析、2023-2030年
出版日: 2023年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

前頭側頭型障害（FTD）は、前頭側頭型認知症または前頭側頭様変性症とも呼ばれ、脳の前頭葉と側頭葉に存在する神経細胞の損傷によって引き起こされます。

この疾患には、思考能力の大幅な低下が含まれ、仕事、運転、食事の準備などの日常生活の遂行能力に影響を及ぼします。また、感情的な問題、仕事の困難、異常な行動、コミュニケーション障害、歩行困難などの症状も含まれます。政府および非政府組織による資金提供の増加、医療治療への支出の増加、治療の有効性に関する意識の高まり、老年人口の増加が、世界中で市場の需要を増大させている主な要因です。

加えて、人口の間で認知症やその他の前頭側頭型障害の発生率が増加していることが、かなりの割合で市場需要を促進している重要な役割を果たしています。

国際アルツハイマー病協会（ADI）によると、2020年には世界中で5,500万人以上が認知症に罹患していると推定されています。また、この数は20年ごとに倍増し、2030年には7,800万人、2050年には1億3,900万人に達すると予測されています。したがって、これらの前述の要因は、推定期間中に前頭側頭型障害治療市場の成長を推進しています。さらに、研究開発活動が重視されるようになり、医薬品の承認が増加していることも、予測期間中にさまざまな有利な機会をもたらしています。例えば、2022年11月、米国食品医薬品局（FDA）は、ALSのための重要な治療法へのアクセスを加速する法律の可決後、希少神経変性疾患助成金プログラムを開始しました。このプログラムでは、ALSをはじめ、小児から成人まで罹患する希少神経変性疾患の治療法を見出すための研究開発に必要な費用について、民間団体や公的機関が助成金や契約を受けることができます。こうした活動は、前頭側頭型障害治療市場のダイナミクスに好影響を与えると予想されます。しかし、熟練した専門家の不足や厳しい政府規制が、2023-2030年の予測期間を通じて市場成長の課題となっています。

前頭側頭型障害治療の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、前頭側頭型障害の有病率の増加、確立された医療施設の存在、研究活動の進歩により、2022年の市場を独占しました。前頭側頭様変性症協会によると、6万人以上の米国人がFTDを患っていると推定され、その数は2050年までに倍増すると予測されています。一方、アジア太平洋地域は、予測期間中最も高いCAGRで成長すると予想されています。対象疾患の症例の増加、高齢化人口の増加、アンメットメディカルニーズの高さ、医療支出の増加が、同地域全体の市場需要を大きく押し上げています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 前頭側頭型障害治療市場：地域別、2020-2030年
    • 前頭側頭型障害治療市場：薬剤クラス別、2020-2030年
    • 前頭側頭型障害治療市場：適応疾患別、2020-2030年
    • 前頭側頭型障害治療市場：流通チャネル別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 前頭側頭型障害治療の世界市場定義とスコープ

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 前頭側頭型障害治療の世界市場力学

  • 前頭側頭型障害治療市場の影響分析（2020-2030年）
    • 市場促進要因
      • 認知症・その他の前頭側頭型疾患の増加
      • 政府・非政府組織による資金提供の増加
    • 市場の課題
      • 熟練した専門家の不足
      • 厳しい政府規制
    • 市場機会
      • 研究開発重視の高まり
      • 承認薬の増加

第4章 前頭側頭型障害治療の世界市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 前頭側頭型障害治療の世界市場：薬剤クラス別

  • 市場スナップショット
  • 前頭側頭型障害治療の世界市場：薬剤クラス別、業績-潜在能力分析
  • 前頭側頭型障害治療の世界市場：薬剤クラス別推定・予測、2020-2030年
  • 前頭側頭型障害治療市場のサブセグメント分析
    • 認知機能改善薬
    • 抗精神病薬
    • 抗うつ薬
    • 中枢神経刺激薬
    • その他の薬剤クラス

第6章 前頭側頭型障害治療の世界市場：適応疾患別

  • 市場スナップショット
  • 前頭側頭型障害治療の世界市場：適応疾患別、業績-潜在能力分析
  • 前頭側頭型障害治療の世界市場：疾患適応症別推定・予測、2020-2030年
  • 前頭側頭型障害治療市場のサブセグメント分析
    • 前頭側頭型認知症
    • 原発性進行性失語症
    • 運動障害

第7章 前頭側頭型障害治療の世界市場：流通チャネル別

  • 市場スナップショット
  • 前頭側頭型障害治療の世界市場：流通チャネル別、業績-潜在能力分析
  • 前頭側頭型障害治療の世界市場：流通チャネル別推定・予測、2020-2030年
  • 前頭側頭型障害治療市場のサブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 前頭側頭型障害治療の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 前頭側頭型障害治療市場、地域別市場スナップショット
  • 北米
    • 米国
      • 薬剤クラスの推定・予測、2020-2030年
      • 疾患適応症別の推定・予測、2020～2030年
      • 流通チャネル別の推定・予測、2020～2030年
    • カナダ
  • 欧州の前頭側頭型障害治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の前頭側頭型障害治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの前頭側頭型障害治療市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Pfizer Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Johnson & Johnson
    • Sanofi S.A.
    • Eli Lilly and Company
    • GlaxoSmithKline Plc.
    • Novartis AG
    • Mylan N.V.
    • Merck & Company, Inc.
    • AstraZeneca plc.
    • Allergen plc

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Frontotemporal Disorders Treatment Market, report scope
  • TABLE 2. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
  • TABLE 4. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Disease Indication 2020-2030 (USD Billion)
  • TABLE 5. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Frontotemporal Disorders Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Frontotemporal Disorders Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Frontotemporal Disorders Treatment Market, research methodology
  • FIG 2. Global Frontotemporal Disorders Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Frontotemporal Disorders Treatment Market, key trends 2022
  • FIG 5. Global Frontotemporal Disorders Treatment Market, growth prospects 2023-2030
  • FIG 6. Global Frontotemporal Disorders Treatment Market, porters 5 force model
  • FIG 7. Global Frontotemporal Disorders Treatment Market, pest analysis
  • FIG 8. Global Frontotemporal Disorders Treatment Market, value chain analysis
  • FIG 9. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Frontotemporal Disorders Treatment Market, regional snapshot 2020 & 2030
  • FIG 15. North America Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia Pacific Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Conventional and Alternative Pain Treatment Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Frontotemporal Disorders Treatment Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Frontotemporal disorders (FTD) are also referred to as frontotemporal dementia or frontotemporal degeneration disease, which is caused due to the damage of neurons present in the frontal and temporal lobes of the brain. This disorder includes a major loss of thinking abilities that affects a person's ability to carry out their daily activities like working, driving, and preparing meals. Also, it encompasses symptoms such as emotional problems, difficulty with work, unusual behaviors, trouble communicating, or difficulty with walking. The rising funding by the government, as well as non-government organizations, increasing expenditure on healthcare treatments, growing awareness regarding treatment availability, and increasing geriatric population, are the major factors that are augmenting the market demand across the globe.

In addition, the increasing incidences of dementia and other frontotemporal disorders among the population are playing a significant role that is propelling the market demand at a considerable rate.

According to Alzheimer's Disease International (ADI), in 2020, it was estimated that there were more than 55 million people worldwide suffering from dementia. Also, this number is anticipated to get double every 20 years, which is projected to reach 78 million by 2030 and 139 million by 2050. Thus, these aforementioned factors are propelling the growth of the Frontotemporal Disorders Treatment Market during the estimated period. Furthermore, the rising emphasis on research and development activities, as well as the increasing drug approvals present various lucrative opportunities over the forecasting years. For instance, in November 2022, the U.S. Food and Drug Administration (FDA) launched its Rare Neurodegenerative Disease Grant Program after the passing Accelerating Access to Critical Therapies for ALS Act. Through this initiative, private and public organizations are able to receive grants and contracts to help with the costs of conducting research and development to find a cure for ALS and other rare neurodegenerative diseases that affect both children and adults. Such activities are anticipated to have a favorable impact on the dynamics of the market for frontotemporal disorders treatment. However, the unavailability of skilled professionals and the stringent government regulations are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Frontotemporal Disorders Treatment Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of frontotemporal disorders, the presence of well-established healthcare facilities and advances in research activities. As per the Association for Frontotemporal Degeneration, more than 60,000 Americans are estimated to be living with FTD, and the number is projected to double by 2050. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising cases of target disorders, increasing aging population, high unmet medical needs, and increasing healthcare expenditure are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Pfizer Inc.
  • Johnson & Johnson
  • Sanofi S.A.
  • Eli Lilly and Company
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Mylan N.V.
  • Merck & Company, Inc.
  • AstraZeneca plc.
  • Allergen plc

Recent Developments in the Market:

  • In April 2022, the US FDA approved Lupin Ltd to put its generic version of the antidepressant medicine Desvenlafaxine extended-release tablets on the market.
  • In December 2021, the US FDA authorized Caplyta (lumateperone) for the treatment of adult bipolar depression. The only medication authorized by the FDA for the treatment of depressive symptoms resulting from bipolar I or bipolar II disorder in adults as monotherapy or adjunctive therapy with either valproate or lithium is Caplyta, an atypical antipsychotic from the biopharmaceutical company Intra-Cellular Therapies.

Global Frontotemporal Disorders Treatment Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Class, Disease Indication, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

  • Cognitive Enhancers
  • Antipsychotics
  • Antidepressants
  • CNS Stimulants
  • Other Drug Classes

By Disease Indication:

  • Frontotemporal Dementia
  • Primary Progressive Aphasia
  • Movement Disorders

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Frontotemporal Disorders Treatment Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Frontotemporal Disorders Treatment Market, by Drug Class, 2020-2030 (USD Billion)
    • 1.2.3. Frontotemporal Disorders Treatment Market, by Disease Indication, 2020-2030 (USD Billion)
    • 1.2.4. Frontotemporal Disorders Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Frontotemporal Disorders Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Frontotemporal Disorders Treatment Market Dynamics

  • 3.1. Frontotemporal Disorders Treatment Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of dementia and other frontotemporal disorders
      • 3.1.1.2. Rising funding by the government as well as non-government organizations
    • 3.1.2. Market Challenges
      • 3.1.2.1. Unavailability of skilled professionals
      • 3.1.2.2. Stringent government regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising emphasis on research and development activities
      • 3.1.3.2. Increasing drug approvals

Chapter 4. Global Frontotemporal Disorders Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Frontotemporal Disorders Treatment Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Global Frontotemporal Disorders Treatment Market by Drug Class, Performance - Potential Analysis
  • 5.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
  • 5.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
    • 5.4.1. Cognitive Enhancers
    • 5.4.2. Antipsychotics
    • 5.4.3. Antidepressants
    • 5.4.4. CNS Stimulants
    • 5.4.5. Other Drug Classes

Chapter 6. Global Frontotemporal Disorders Treatment Market, by Disease Indication

  • 6.1. Market Snapshot
  • 6.2. Global Frontotemporal Disorders Treatment Market by Disease Indication, Performance - Potential Analysis
  • 6.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Billion)
  • 6.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
    • 6.4.1. Frontotemporal Dementia
    • 6.4.2. Primary Progressive Aphasia
    • 6.4.3. Movement Disorders

Chapter 7. Global Frontotemporal Disorders Treatment Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Frontotemporal Disorders Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacies
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Online Pharmacies

Chapter 8. Global Frontotemporal Disorders Treatment Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Frontotemporal Disorders Treatment Market, Regional Market Snapshot
  • 8.4. North America Frontotemporal Disorders Treatment Market
    • 8.4.1. U.S. Frontotemporal Disorders Treatment Market
      • 8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Disease Indication breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Frontotemporal Disorders Treatment Market
  • 8.5. Europe Frontotemporal Disorders Treatment Market Snapshot
    • 8.5.1. U.K. Frontotemporal Disorders Treatment Market
    • 8.5.2. Germany Frontotemporal Disorders Treatment Market
    • 8.5.3. France Frontotemporal Disorders Treatment Market
    • 8.5.4. Spain Frontotemporal Disorders Treatment Market
    • 8.5.5. Italy Frontotemporal Disorders Treatment Market
    • 8.5.6. Rest of Europe Frontotemporal Disorders Treatment Market
  • 8.6. Asia-Pacific Frontotemporal Disorders Treatment Market Snapshot
    • 8.6.1. China Frontotemporal Disorders Treatment Market
    • 8.6.2. India Frontotemporal Disorders Treatment Market
    • 8.6.3. Japan Frontotemporal Disorders Treatment Market
    • 8.6.4. Australia Frontotemporal Disorders Treatment Market
    • 8.6.5. South Korea Frontotemporal Disorders Treatment Market
    • 8.6.6. Rest of Asia Pacific Frontotemporal Disorders Treatment Market
  • 8.7. Latin America Frontotemporal Disorders Treatment Market Snapshot
    • 8.7.1. Brazil Frontotemporal Disorders Treatment Market
    • 8.7.2. Mexico Frontotemporal Disorders Treatment Market
  • 8.8. Middle East & Africa Frontotemporal Disorders Treatment Market
    • 8.8.1. Saudi Arabia Frontotemporal Disorders Treatment Market
    • 8.8.2. South Africa Frontotemporal Disorders Treatment Market
    • 8.8.3. Rest of Middle East & Africa Frontotemporal Disorders Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Pfizer Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Johnson & Johnson
    • 9.3.3. Sanofi S.A.
    • 9.3.4. Eli Lilly and Company
    • 9.3.5. GlaxoSmithKline Plc.
    • 9.3.6. Novartis AG
    • 9.3.7. Mylan N.V.
    • 9.3.8. Merck & Company, Inc.
    • 9.3.9. AstraZeneca plc.
    • 9.3.10. Allergen plc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption